Haven't used Sophiris Bio yet?
Ask Trustburn

Ask Trustburn about Sophiris Bio

Based on 11 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Kevin Austin
Reviews 1

The services provided by Sophiris Bio are absolutely excellent. I'm really impressed with their professionalism and expertise. They are always thorough in their work and deliver results that exceed expectations. I highly recommend them!

Mark Hardiek
Reviews 1

I've been a customer of Sophiris Bio for several months now, and I must say, their services have greatly exceeded my expectations. The team is knowledgeable, professional, and always goes above and beyond to ensure customer satisfaction. Keep up the good work!

Charles Rawsthorne
Reviews 1

I recently used the services provided by a certain company, and I must say, I'm really impressed. Their team was very helpful throughout the process, and they delivered results that were beyond my expectations. I would definitely recommend their services!

Danielle Eyre
Reviews 1

I recently had the opportunity to work with Sophiris Bio, and I must say, I'm extremely satisfied with their services. Their team is highly professional and knowledgeable, and they provide exceptional customer support. I would definitely recommend them!

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="sophiris-com" data-lang="en"></div>
More widgets

About Sophiris Bio

Sophiris Bio Inc. (NASDAQ: SPHS) is a biopharmaceutical company developing a clinical-stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH or enlarged prostate), which it believes is an unsatisfied patient population with significant market potential. Sophiris is currently developing PRX302 for the treatment of BPH symptoms which is designed to be as efficacious as pharmaceuticals, less invasive than the surgical interventions, and without the sexual side effects seen with existing treatments. PRX302 is currently in Phase 3 clinical development with a blinded interim analysis expected in the second half of 2014 followed by a complete data analysis in the second half of 2015. For more information, please visit www.sophiris.com.